Investor Video Call // March 04, 2026 // 2:00 p.m. CET
Q4/Fiscal Year 2025 Results
Investor News March 04, 2026
Bayer delivers upgraded 2025 ambition, projects solid 2026, focused on strategic priorities
Top row, from left to right: Bill Anderson, Chairman / Wolfgang Nickl, Finance / Stefan Oelrich, Pharmaceuticals
Lower row, from left to right: Rodrigo Santos, Crop Science / Julio Triana, Consumer Health
